Related Subjects:
| Alcohol Metabolism
π· Up to 90% of alcohol consumed is metabolised in the liver. The process involves enzymatic pathways converting ethanol β acetaldehyde (toxic) β acetate (less harmful, excreted as COβ + HβO).
β οΈ Acetaldehyde and reactive oxygen species (ROS) drive much of alcoholβs tissue damage, especially in the liver.
𧬠Pathways of Alcohol Metabolism
- Alcohol Dehydrogenase (ADH) Pathway π :
- Primary route in hepatocytes.
- ADH converts ethanol β acetaldehyde.
- Acetaldehyde β acetate via ALDH (aldehyde dehydrogenase).
- Excess acetaldehyde β flushing, nausea, DNA damage, carcinogenicity.
- Microsomal Ethanol-Oxidizing System (MEOS) π₯ :
- Activated in chronic heavy drinkers.
- Cytochrome P450 system (mainly CYP2E1).
- Generates ROS β lipid peroxidation, mitochondrial injury, hepatocyte apoptosis.
- Explains why chronic drinkers metabolise alcohol faster but suffer more organ damage.
- Catalase Pathway π§ͺ :
- Minor contribution, uses hydrogen peroxide (HβOβ).
- More relevant in brain tissue metabolism of alcohol.
βοΈ Factors Affecting Alcohol Metabolism
- Genetics 𧬠:
- ADH/ALDH polymorphisms alter metabolism.
- ALDH2 deficiency (common in East Asians) β flushing, palpitations, β oesophageal cancer risk.
- Gender πΊ vs πΉ :
- Women: lower gastric ADH activity β higher BAC for same intake.
- Age π :
- Older adults: slower hepatic metabolism β prolonged effects.
- Food Intake π½οΈ :
- Delays gastric emptying β lowers peak BAC.
- Chronic Drinking π» :
- Induces CYP2E1 β faster ethanol clearance, more ROS β β cirrhosis and cancer risk.
𧨠Effects of Alcohol Metabolism
- Acute πΈ :
- CNS depression β impaired coordination, judgement.
- Hangover: acetaldehyde toxicity (headache, nausea, sweating).
- Chronic π©Έ :
- Liver: fatty change β hepatitis β fibrosis β cirrhosis β hepatocellular carcinoma.
- Cancer: β risk of oral, oesophageal, liver cancers (acetaldehyde carcinogenicity).
- Cardiovascular: dilated cardiomyopathy, arrhythmias, hypertension.
- Neurology: peripheral neuropathy, WernickeβKorsakoff syndrome (thiamine deficiency).
- Tolerance & Dependence π :
- MEOS induction β tolerance (need more alcohol for same effect).
- Dependence: cravings, withdrawal (tremor, seizures, delirium tremens).
π§ͺ Diagnosis
- π Blood alcohol concentration (BAC).
- π©Ί Liver function tests (β ALT, AST, GGT, bilirubin).
- π MCV and CDT (carbohydrate-deficient transferrin) may indicate chronic misuse.
- π§Ύ Screening tools: AUDIT questionnaire, CAGE questions.
π Treatment
- Behavioural Therapies π§ :
- CBT, motivational interviewing, relapse prevention, peer support (AA).
- Medications π :
- Disulfiram β inhibits ALDH β acetaldehyde buildup β unpleasant reaction if alcohol consumed.
- Naltrexone β reduces cravings (opioid receptor antagonist).
- Acamprosate β modulates glutamate/GABA β helps maintain abstinence.
- Lifestyle & Medical πββοΈπ₯ :
- Balanced nutrition, vitamin supplementation (esp. thiamine B1).
- Detoxification under medical supervision if dependent (prevent seizures/DTs).
- Rehabilitation programmes, inpatient units if severe.
π Summary
Alcohol metabolism mainly occurs via the ADH β ALDH pathway in the liver. Genetics, gender, diet, and chronic intake all influence metabolism.
π‘ Key clinical relevance: Acetaldehyde & ROS drive tissue damage β cirrhosis, cancer, neuropathy.
Effective management requires a mix of medical, psychological, and lifestyle interventions.